Status:
COMPLETED
A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans
Lead Sponsor:
RAND
Conditions:
HIV/AIDS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Project Rise is a randomized controlled trial (RCT) of an innovative, culturally congruent treatment education (TE) intervention for African Americans with HIV that targets cultural and social issues ...
Detailed Description
Project Rise is a randomized controlled trial (RCT) of an innovative, culturally congruent treatment education (TE) intervention for African Americans with HIV that targets cultural and social issues ...
Eligibility Criteria
Inclusion
- HIV-positive
- 18 years of age or older
- Self-identified as African American/Black
- Been prescribed antiretroviral therapy (ART) in the past 12 months
- Self-reported adherence problems (i.e. missed at least 1 ART dose in the past month) and/or detectable viral load
- Willing to use Medication Events Monitoring System (MEMS) for electronic adherence monitoring.
Exclusion
- HIV-negative
- 17 years of age or younger
- Not self-identified as African American/Black, not on antiretroviral therapy (ART) or not prescribed ART therapy in the last than 12 months
- No self-reported adherence problems and/or no detectable viral load
- Not willing to use Medication Events Monitoring System (MEMS) for electronic adherence monitoring.
Key Trial Info
Start Date :
January 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 7 2021
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT03331978
Start Date
January 23 2018
End Date
November 7 2021
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AIDS Project Los Angeles
Los Angeles, California, United States, 90016